Active immunization against Alzheimer's beta-amyloid peptide using phage display technology

Area of Science:

• Neuroscience
• Immunology
• Biotechnology

Background:

• Beta-amyloid peptide (AbetaP) aggregation is an early event in Alzheimer's disease (AD) pathogenesis.
• AbetaP aggregation is a key therapeutic target for AD treatments.

Purpose of the Study:

• To develop an immunization strategy targeting AbetaP for AD therapeutics.
• To investigate the impact of bacteriophage displaying varying copies of self-epitope on immune response intensity.

Main Methods:

• Developed an immunization procedure using filamentous phage displaying the EFRH peptide (N-terminal region of AbetaP) as antigen.
• Raised antibodies against AbetaP using the developed immunization method.
• Evaluated the efficacy in a transgenic (Tg) mouse model of AD.

Main Results:

• Demonstrated that bacteriophages displaying different numbers of self-epitope copies modulate immune response intensity.
• The immunization procedure led to significant improvements in cognitive functions in AD model mice.
• Observed alleviation of amyloid pathology in the transgenic mouse model.

Conclusions:

• The bacteriophage-based immunization strategy is effective in generating anti-AbetaP antibodies.
• This approach shows therapeutic potential for improving cognitive deficits and reducing amyloid pathology in Alzheimer's disease.